Article type
Abstract
Background: Due to diagnosis and treatment, lung cancer patients have a serious burden of symptoms and need simple and feasible symptom management measures imminently. To manage the most common fatigue-pain-sleep disturbance symptom cluster in patients, the formation of non-pharmacological management measures based on evidence summary would provide medical staff and patients with scientific, implementable, and low-cost symptom management measures, alleviate the symptom burden of patients during treatment, improve patients' treatment confidence, and improve adverse outcomes.
Aim: To summarize the best available evidence on non-pharmacological interventions for the fatigue-pain-sleep disturbance symptom cluster in lung cancer patients, and provide evidence-based methods for the management to clinicians and lung cancer patients.
Method: The guidelines, best practice recommendations, evidence summaries, clinical practices, expert consensus, and systematic reviews on the management of the fatigue-pain-sleep disturbance symptom cluster in lung cancer patients were searched systematically in the Guidelines Website, Association Website, Up To Date, BMJ Best Practice, PubMed, Embase, the Cochrane Library, CINAHL, CBM, CNKI, WanFang database, the unpublished grey pieces of literature were searched through Google, Baidu Academic and other search engines. The retrieval time was from the establishment of databases to September 2023. Two researchers trained in evidence-based knowledge independently evaluated the quality of the included literature, and extracted and summarized the evidence.
Results: A total of 52,094 pieces of literature were retrieved, 57 pieces of literature were included, including 18 guidelines, 19 JBI best practice recommendations, 1 Up To Date clinical practice, and 19 systematic reviews. 49 pieces of evidence from 6 dimensions of screening, assessment, management, education, referral, and follow-up were summarized.
Conclusion: The best 49 pieces of evidence of non-pharmacological interventions for the fatigue-pain-sleep disturbance symptom cluster in lung cancer patients summarized in this study are scientific and comprehensive, which can guide clinicians and lung cancer patients to improve the symptom management effect. The process of evidence in this study transformation needs to be carried out based on localization and combined with the actual clinical situation. Future research should constantly update and supplement the evidence content, refine the evidence items, and improve the operability of evidence.
Aim: To summarize the best available evidence on non-pharmacological interventions for the fatigue-pain-sleep disturbance symptom cluster in lung cancer patients, and provide evidence-based methods for the management to clinicians and lung cancer patients.
Method: The guidelines, best practice recommendations, evidence summaries, clinical practices, expert consensus, and systematic reviews on the management of the fatigue-pain-sleep disturbance symptom cluster in lung cancer patients were searched systematically in the Guidelines Website, Association Website, Up To Date, BMJ Best Practice, PubMed, Embase, the Cochrane Library, CINAHL, CBM, CNKI, WanFang database, the unpublished grey pieces of literature were searched through Google, Baidu Academic and other search engines. The retrieval time was from the establishment of databases to September 2023. Two researchers trained in evidence-based knowledge independently evaluated the quality of the included literature, and extracted and summarized the evidence.
Results: A total of 52,094 pieces of literature were retrieved, 57 pieces of literature were included, including 18 guidelines, 19 JBI best practice recommendations, 1 Up To Date clinical practice, and 19 systematic reviews. 49 pieces of evidence from 6 dimensions of screening, assessment, management, education, referral, and follow-up were summarized.
Conclusion: The best 49 pieces of evidence of non-pharmacological interventions for the fatigue-pain-sleep disturbance symptom cluster in lung cancer patients summarized in this study are scientific and comprehensive, which can guide clinicians and lung cancer patients to improve the symptom management effect. The process of evidence in this study transformation needs to be carried out based on localization and combined with the actual clinical situation. Future research should constantly update and supplement the evidence content, refine the evidence items, and improve the operability of evidence.